UNSPSC 51373332: Atropine/meperidine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373332 Atropine/meperidine, a Commodity code, encompasses emergency and therapeutic pharmaceutical products that state and local health agencies, community health programs, and cooperative purchasing alliances procure through competitive bidding and request-for-proposal processes. Recent state and local solicitations under this code show demand for naloxone and opioid-countermeasure systems alongside broader generic pharmaceutical sourcing through established wholesaler networks, reflecting public health priorities in emergency response and controlled substance management. State and local governments use this code to acquire emergency medications, safety-related pharmaceutical systems, and generics distributed through authorized pharmacy benefit channels, often with quarterly or ongoing delivery schedules to multiple facilities within a jurisdiction.

Issuing bodies span county health departments, state health and human services commissions, and multistate cooperative purchasing alliances. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (response due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to explore direct-to-manufacturer prescription programs and vendor capabilities for therapeutic pharmacy initiatives, seeking market intelligence before formal procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026 (response due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, with pricing weighted 75 percent in the evaluation and awarded vendors required to maintain relationships with AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson wholesalers. Recent activity concentrates in Florida, Texas, and the Upper Midwest cooperative purchasing region.